New feeding strategy may stop leaky lymph fluid after esophageal surgery
NCT ID NCT07616245
First seen Jun 03, 2026 · Last updated Jun 17, 2026 · Updated 1 time
Summary
This study tests whether using a special formula (MCT) for tube feeding right after esophageal cancer surgery can prevent chyle leak, a complication where lymph fluid leaks into the chest. About 160 adults having minimally invasive surgery for esophageal cancer will be randomly assigned to get either MCT or standard tube feeds. The goal is to see if MCT feeds reduce the number of chyle leaks and help patients recover faster.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beaumont RCSI Cancer Centre
RECRUITINGBeaumont, Dublin, D09V2N0, Ireland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.